Novan
Stanley Hollenbach began their work experience in 2004 at Portola Pharmaceuticals, Inc. where they served as Vice President of Pharmacology until 2014. In 2014, Hollenbach joined Novan Therapeutics as Vice President of Research and Nonclinical Development and later became the Senior Vice President of Research and Development in 2017. Stanley worked at Novan Therapeutics until 2022. In 2018, Hollenbach joined Ambys Medicines, Inc. as Senior Vice President of Pharmacology, a role they held until present.
Stanley Hollenbach attended the University of North Carolina at Charlotte from 1976 to 1981. No specific degree or field of study was mentioned.
Novan
Novan, Inc. is a late-stage pharmaceutical company focused on redefining the standard of care in dermatology through the development and commercialization of innovative therapies using the Company’s nitric oxide platform.